Company: BIAF
Filing Date: 2025-10-09
Form Type: 424B5
Source: 0001493152-25-017591
Chunk: 108

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-10-09
Form: 424B5
Chunk 108
---
 of the securities offered by this prospectus.

We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public at the SEC’s website at www.sec.gov. Our SEC filings are also available on our website, www.bioaffinitytech.comunder the heading “Investor Relations—SEC Filings.” The reference to our website is an inactive textual reference only, and the information contained in, and that can be accessed through our website, is not incorporated into and is not a part of this prospectus. We make available on our website our SEC filings as soon as reasonably practicable after those reports are filed with the SEC.

| 49 |

<div align='center'>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

The SEC allows us to “incorporate by reference” information into this prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The SEC file number for the documents incorporated by reference in this prospectus is 001-41463. The documents incorporated by reference into this prospectus contain important information about us that you should read.

The following documents are incorporated by reference into this prospectus:

| ● 
 ● | Our                                                                                                                                 
 Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 31, 2023;                       
 Our                                                                                                                                 
 Quarterly Report on Form                                                                                                            
 10-Q for the fiscal quarter ended March 31, 2023, filed with the SEC on May 15, 2023, our Quarterly Report on Form                  
 10-Q for the quarter ended June 30, 2023, filed with the SEC on August 14, 2023 , and our Quarterly Report on Form 10-Q for         
 the quarter ended September 30, 2023, filed with the SEC on November 14, 2023;                                                      |
|:--|:------------------------------------------------------------------------------------------------------------------------------------|
| ● | Our                                                                                                                                 
 Current Reports on Form 8-K filed with the SEC on January                                                                           
 4, 2023, January                                                                                                                    
 24, 2023, February                                                                                                                  
 13, 2023, March                                                                                                                     
 24, 2023, as amended, March                                                                                                         
 24, 2023, March                                                                                                                     
 28, 2023, April                                                                                                                     
 5, 2023, April